US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
All News
Headline News
Barchart.com
Benzinga
BreakingCrypto
Chartmill
Finterra
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
MarketMinute
PredictStreet
StockStory
Stocktwits
Talk Markets
TokenRing AI
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Actusnews Wire
Authority Press Wire
B2i Digital
Brandpoint
BusinesNews Wire
Business Wire
CannabisNewsWire
CryptoCurrencyWire
FinancialNewsMedia
First Publisher
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
NewMediaWire
Newsfile
NewsUSA
Newswire.com
PR Underground
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
PulseBulletin.com
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
TheNewswire
Visibility
Worldnewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Canadian Pacific Kansas City Sees Strongest Quarter as Grain and Intermodal Volumes Surge
↗
Today 13:12 EST
Via
MarketBeat
Topics
Economy
Tickers
CP
Exposures
Coal
Economy
AbCellera Biologics Targets 2027 Phase 3 Trial for Hot Flash Drug
↗
Today 12:12 EST
Via
MarketBeat
Tickers
ABCL
UBS
J.B. Hunt Targets Margin Recovery in 2027 as Costs Rise and Fleet Expands
↗
Today 11:12 EST
Via
MarketBeat
Tickers
JBHT
Growing Pains Versus Growth: Is BJ’s Wholesale Club a Buying Opportunity?
↗
Today 10:25 EST
Via
MarketBeat
Tickers
BJ
Neurocrine Biosciences Sees INGREZZA Growth, Awaits Key 2027 Trial Results
↗
Today 10:12 EST
Via
MarketBeat
Topics
Intellectual Property
Tickers
NBIX
Exposures
Intellectual Property
Keysight Technologies: The Tollbooth on the Technology Superhighway
↗
Today 9:35 EST
Via
MarketBeat
Tickers
KEYS
Compass Pathways Sees Potential Fast FDA Review for Psilocybin Depression Treatment
↗
Today 9:12 EST
Via
MarketBeat
Topics
Cannabis
Government
Tickers
CMPS
Exposures
Cannabis
Political
Product Safety
Zscaler Got a Boost From Palo Alto, But Now It Has to Deliver.
↗
Today 8:45 EST
Via
MarketBeat
Tickers
PANW
ZS
Abeona Therapeutics Sees ZEVASKYN Treatments Picking Up in 2027 as Centers Ramp Up
↗
Today 8:12 EST
Via
MarketBeat
Tickers
ABEO
Exposures
Product Safety
Bargain Hunting: Why Off-Price Retail Is Winning
↗
Today 7:55 EST
Via
MarketBeat
Tickers
BURL
ROST
TJX
Hikma Pharmaceuticals Confident on 2026 Targets Despite Flat Injectables Sales
↗
Today 7:12 EST
Via
MarketBeat
Topics
Supply Chain
Exposures
Supply Chain
Guardant Health Sees Shield Coverage Boost in 2027, Holds Cash Flow Break-Even Target
↗
Today 6:12 EST
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
GH
Exposures
Artificial Intelligence
F5 Sees AI and Software Renewals Driving Growth After $100 Million in AI Bookings
↗
Today 5:12 EST
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
FFIV
NVDA
Exposures
Artificial Intelligence
Magnite Targets Global Markets and Live Sports After 39% CTV Growth
↗
Today 4:12 EST
Via
MarketBeat
Tickers
MGNI
ROKU
Citizens Financial Group Targets $450 Million Tech Boost as Private Banking Grows
↗
Today 3:12 EST
Via
MarketBeat
Tickers
CFG
JPM
Nektar Therapeutics Maps Key REZPEG Data Milestones for 2027 and 2028
↗
Today 1:12 EST
Via
MarketBeat
Tickers
NKTR
UBS
Ardelyx Targets 2027 Profitability as IBSRELA Faces Insurance Hurdles
↗
Today 0:12 EST
Via
MarketBeat
Tickers
ARDX
Quest Diagnostics Sees Hospital Deal Growth as 2027 Medicare Cuts Loom
↗
November 21, 2026
Via
MarketBeat
Tickers
DGX
Lakefront Biotherapeutics Eyes 2027 Trials for Autoimmune Drug, Backed by €2.2 Billion in Cash
↗
November 21, 2026
Via
MarketBeat
Tickers
GILD
LKFT
Nasdaq Targets 2027 Equity Token Launch as AI and FinTech Growth Accelerate
↗
November 21, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Fraud
Tickers
JPM
NDAQ
Exposures
Artificial Intelligence
Legal
Paychex Weighs Florida Insurance Shift as Outsourced HR Business Grows
↗
November 21, 2026
Via
MarketBeat
Topics
Economy
Tickers
PAYX
Exposures
Economy
RingCentral Bets on AI Growth as Paid AI ARR Doubles and Margins Hold Firm
↗
November 21, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
RNG
RY
TSX:RY
Exposures
Artificial Intelligence
Nektar Therapeutics Targets December for Phase 3 Alopecia Trial as REZPEG Advances
↗
November 21, 2026
Via
MarketBeat
Tickers
NKTR
Canadian National Railway Adds C$300 Million in Revenue as Port Outage Clouds Q4
↗
November 21, 2026
Via
MarketBeat
Tickers
CNI
Nasdaq Starts Charging for Financial Crime AI Agents as 850 Customers Sign On
↗
November 21, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
NDAQ
RY
TSX:RY
Exposures
Artificial Intelligence
Mesoblast Eyes Heart Failure Filing as Back Pain Trial and RYONCIL Expansion Advance
↗
November 21, 2026
Via
MarketBeat
Tickers
ASX:MSB
MESO
Deutsche Bank Sees 2026 Revenue Above €33 Billion, Reaffirms Cost Target
↗
November 21, 2026
Via
MarketBeat
Tickers
DB
JPM
RIVN
TSLA
ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
↗
November 21, 2026
Via
MarketBeat
Tickers
ZIM
SAP CFO Sees Headcount Declining as AI Boosts Productivity, Plans New Revenue Metric
↗
November 21, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tickers
COST
MS
SAP
Exposures
Artificial Intelligence
Owens Corning's Stock Slump May Have a Silver Lining for Dividend Investors
↗
November 21, 2026
Via
MarketBeat
Tickers
GLW
OC
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >